Effect of long term treatment with salmeterol on asthma control: A double blind, randomised crossover study

British Medical Journal

Volumn 314, Issue 7092, 1997, Pages 1441-1446

  Wilding, Paul ^a   Clark, Miranda ^a   Coon, Joanna Thompson ^a   Lewis, Sarah ^a   Rushton, Lesley ^b   Bennett, Jon ^a   Oborne, Janet ^a   Cooper, Susan ^a   Tattersfield, Anne E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; IPRATROPIUM BROMIDE; PLACEBO; PREDNISOLONE; SALMETEROL; STEROID; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; FEMALE; HAIR LOSS; HEART PALPITATION; HEART RATE; HUMAN; HYPOKALEMIA; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; THORAX PAIN; TREMOR;

EID: 0030965337     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7092.1441     Document Type: Article

References (28)

1. Ullman A, Svedmyr N. Salmeterol, a new long acting inhaled β2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-8.
2. Campos-Gongora H, Wisniewski AF, Tattersfield AE. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis 1991;144:626-9.
3. Sears MR, Taylor DR, Print CG, Lake DC, Li Q, Flannery EM, et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
4. Pearlman DS, Chervinski P, LaForce C, Seltzer JM, Southern DL, Kemp JP, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
5. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994;271:1412-6.
6. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet L-P, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995;151:66-70.
7. 2 agonist. BMJ 1990;301:1365-8.
8. Dahl R, Earnshaw JS, Palmer JBD. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991;4:1178-84.
9. Jones KP. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. Thorax 1994;49:971-5.
10. Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992;5:1062-7.
11. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993;48:148-53.
12. Roberts JA, Bradding P, Walls AF, Holgate ST, Howarth PH. The effect of salmeterol xinafoate therapy on lavage findings in asthma. Am Rev Respir Dis 1992;145:A418.
13. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-11.
14. British guidelines on asthma management. Thorax 1997;52(suppl 1).
15. International Asthma Management Project International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992;22:1-72.
16. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983;38:760-5.
17. Jones B, Kenward M. Design and analysis of crossover trials. London: Chapman and Hall, 1989.
18. Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7.
19. Apter AJ, Reisine ST, Willard A, Clive J, Wells M, Metersky M, et al. The effect of inhaled albuterol in moderate to severe asthma. J Allergy Clin Immunol 1996;98:295-301.
20. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in patients who require regular bronchodilator treatment. BMJ 1992;306:1034-7.
21. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995;346:201-6.
22. Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. Am Rev Respir Dis 1990;142:571-5.
23. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;ii:554-8.
24. O'Connor BJ, Aikman SL, Barnes PJ. Tolerance to the nonbronchodilator effects of inhaled β2-agonists in asthma. N Engl J Med 1992;327:1204-8.
25. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-203.
26. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
27. Smyth ET, Pavord ID, Wong CS, Wisniewski AF, Williams J, Tattersfield AE. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ 1993;306:543-5.
28. Bennett JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE. Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 1994;49:771-4.